EVAX   $0.92  -2.13% Market Closed After Close 0.912 -0.87%

Evaxion Biotech A/S
Total Cash 4.58M
totalCashPerShare 0.083
EBITDA -14.87M
Total Debt 0.00
quickRatio
currentRatio
Total Revenue 3.29M
debtToEquity
Revenue/Share 0.713
ROA -0.69451
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -0.57375
profitMargins 0.0
enterpriseValue 137.43M
forwardPE -2.0396824
floatShares 35.89M
sharesOutstanding 5.58M
sharesShort 67.41K
sharesShortPriorMonth 22.05K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.08%
Short Ratio help_outline 0.72%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.013
Price To Book help_outline 197.69
earningsQuarterlyGrowth
netIncomeToCommon -11.46M
trailingEps -2.75%
forwardEps -1.26%
enterpriseToEbitda -9.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.26 4Q 2024
institutionsCount 7
lastUpdated Nov. 7, 2024, 4:54 a.m.